Discrepancies between cytology, cystoscopy and biopsy in bladder cancer detection after Bacille Calmette-Guerin intravesical therapy: Original Article: Clinical Investigation

International Journal of Urology

Volumn 16, Issue 2, 2009, Pages 192-195

  Hara, Tomohiko ^a   Takahashi, Mutsuo ^b   Gondo, Toshikazu ^b,c   Nagao, Kazuhiro ^a   Ohmi, Chietaka ^a   Sakano, Shigeru ^a   Naito, Katsusuke ^a   Matsuyama, Hideyasu ^a  

^a YAMAGUCHI UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

^b YAMAGUCHI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^c YAMAGUCHI UNIVERSITY HOSPITAL   (Japan)

Author keywords

Bacille Calmette Guerin; Bladder biopsy; Bladder cancer; Bladder carcinoma in situ; Urine cytology

Indexed keywords

BCG VACCINE;

ADULT; AGED; ARTICLE; BCG VACCINATION; BLADDER BIOPSY; BLADDER CANCER; CANCER DIAGNOSIS; CANCER GRADING; CANCER PATIENT; CANCER THERAPY; CLINICAL EVALUATION; CYSTOSCOPY; FEMALE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; TUMOR BIOPSY; URINALYSIS; URINE CYTOLOGY; UROTHELIUM;

AGED; AGED, 80 AND OVER; BCG VACCINE; BIOPSY; CARCINOMA; CYSTOSCOPY; FEMALE; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; URINARY BLADDER; URINARY BLADDER NEOPLASMS; URINE;

EID: 60349099848     PISSN: 09198172     EISSN: 14422042     Source Type: Journal    
DOI: 10.1111/j.1442-2042.2008.02200.x     Document Type: Article

References (16)

1. Van Der Meijden APM, Sylvester R, Oosterlinck W et al. EAU guidelines on the diagnosis and treatment of urothelial carcinoma in situ. Eur. Urol. 2005 48 : 363 71.
2. Lamm DL, Blumenstein BA, Crissman JD et al. Maintenance bacillus Calmette-Guerin immunotherapy for recurrent Ta, T1 and carcinoma in situ transitional cell carcinoma of the bladder: A randomized Southwest Oncology Group study. J. Urol. 2000 163 : 1124 9.
3. Jakse G, Hall R, Bono A et al. Intravesical BCG in patients with carcinoma in situ of the urinary bladder: Long-term results of EORTC GU Group Phase II Protocol 30861. Eur. Urol. 2001 40 : 144 50.
4. Zaak D, Hungerhuber E, Schneede P et al. Role of 5-aminolevulinic acid in the detection of urothelial premalignant lesions. Cancer 2002 95 : 1234 8.
5. Guy L, Savareux L, Molinie V, Botto H, Boiteux J-P, Lebret T. Should bladder biopsies be performed routinely after Bacillus Calmette-Guerin treatment for high-risk superficial transitional cell cancer of the bladder? Eur. Urol. 2006 50 : 516 20.
6. Highshaw RA, Tanaka ST, Evans CP, DeVere White RW. Is bladder biopsy necessary at three or six months post BCG therapy? Semin. Urol. Oncol. 2003 207 9.
7. Matsumoto H, Wada T, Fukunaga K, Yoshihiro S, Matsuyama H, Naito K. Bax to Bcl-2 ratio and Ki-67 index are useful predictors of neoadjuvant chemoradiation therapy in bladder cancer. Jpn. J. Clin. Oncol. 2004 34 : 124 30.
8. Kurth KH, Schellhammer PF, Okajima E et al. Current methods of assessing and treating carcinoma in situ of the bladder with or without involvement of the prostatic urethra. Int. J. Urol. 1995 2 : 8 22.
9. Sobin LH, Wittekind C. TNM Classification of Malignant Tumours. 6th edn. Hoboken, New Jersey, John Wiley & Sons, 1997.
10. Epstein JI, Amin MB, Reuter VR et al. The World Health Organization/International Society of Urological Pathology consensus classification of urothelial (transitional cell) neoplasms of the urinary bladder. Am. J. Surg. Pathol. 1998 22 : 1435 48.
11. Papanicolaou GN. Criteria of Malignancy. In : Papanicolaou GN (ed). Atlas of Exfoliative Cytology. Harvard University Press, Cambridge, MA, 1954 13 21.
12. Dalbagni G, Rechtschaffen T, Herr HW. Is transurethral biopsy of the bladder necessary after 3 months to evaluate response to bacillus Calmette-Guerin therapy? J. Urol. 1999 162 : 708 9.
13. Raab SS, Grzybicki DM, Vrbin CM, Geisinger KR. Urine cytology discrepancies: Frequency, causes, and outcomes. Am. J. Clin. Pathol. 2007 127 : 946 53.
14. Parwani AV, Levi AW, Epstein JI, Ali SZ. Urinary bladder biopsy with denuded mucosa: Denuding Cystitis-Cytopathologic correlates. Diagn Cytopathol. 2004 30 : 297 300.
15. Leong AS, Wannakrairot P, Jose J, Milios J. Bacillus Calmette-Guerin- treated superficial bladder cancer: Correlation of morphology with immunophenotyping. J. Pathol. 1990 162 : 35 41.
16. Owens CL, Epstein JI. Significance of denuded urothelium in papillary urothelial lesions. Am. J. Surg. Pathol. 2007 31 : 298 303.